Making no-arbitrage discounting-invariant: A new FTAP version beyond NFLVR and NUPBR
Frontiers of Mathematical Finance · 2022
DOI: 10.3934/fmf.2021010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers of Mathematical Finance, 2022. Verfasst von Dániel Ágoston Bálint und 1 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
What is absence of arbitrage for non-discounted prices? How can one define this so that it does not change meaning if one decides to discount after all?
The answer to both questions is a new discounting-invariant no-arbitrage concept. As in earlier work, we define absence of arbitrage as the zero strategy or some basic strategies being maximal. The key novelty is that maximality of a strategy is defined in terms of share holdings instead of value. This allows us to generalise both NFLVR, by dynamic share efficienc, and NUPBR, by dynamic share viability. These new concepts are the same for discounted or undiscounted prices, and they can be used in general models under minimal assumptions on asset prices. We establish corresponding versions of the FTAP, i.e., dual characterisations in terms of martingale properties. As one expects, "properly anticipated prices fluctuate randomly", but with an endogenous discounting process which cannot be chosen a priori. An example with N geometric Brownian motions illustrates our results.
Zitieren
APA
Bálint, D. Á., & Schweizer, M. (2022). Making no-arbitrage discounting-invariant: A new FTAP version beyond NFLVR and NUPBR. Frontiers of Mathematical Finance. https://doi.org/10.3934/fmf.2021010
Vancouver
Bálint DÁ, Schweizer M. Making no-arbitrage discounting-invariant: A new FTAP version beyond NFLVR and NUPBR. Frontiers of Mathematical Finance. 2022. doi:10.3934/fmf.2021010
BibTeX
@article{Blint2022,
author = {Bálint, Dániel Ágoston and Schweizer, Martin},
title = {Making no-arbitrage discounting-invariant: A new FTAP version beyond NFLVR and NUPBR},
journal = {Frontiers of Mathematical Finance},
year = {2022},
doi = {10.3934/fmf.2021010}
}
EUVIMED